<DOC>
	<DOC>NCT00424372</DOC>
	<brief_summary>To evaluate the safety of the long-term use of pregabalin.</brief_summary>
	<brief_title>A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients who completed the 13week treatment of postherpetic neuralgia in Study A0081120. Patients must be able to understand and cooperate with study procedures and have signed a written informed consent prior to entering the study. Patients who experienced serious adverse events in the preceding study (A0081120) that were determined by the investigator or the study sponsor to be causally related to the study medication. Patients exhibiting treatment noncompliance in the preceding study (A0081120)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>